Kevin Bielamowicz
Medical Director of Brain Tumor Program · University of Arkansas for Medical Sciences (UAMS) College of Medicine
Credentials: · · · · ·
History
PresentBrain Tumor Program · University of Arkansas for Medical Sciences (UAMS) College of Medicine
- Present
Innovative Cancer Therapeutics · University of Arkansas for Medical Sciences (UAMS) College of Medicine
- 2000–2004
Research
JAMA Oncology · 2017 · 747 citations
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
Journal of Clinical Investigation · 2016 · 595 citations
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Neuro-Oncology · 2018 · First of 13 authors · 371 citations
11 papers
8 papers
5 papers · 3 as a fellow
4 papers
3 papers · 2 as a resident
3 papers
- CK
3 papers
3 papers · 3 as a fellow
Clinical trials
- 2022–2025
Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study)
Principal investigator · Completed · Phase 2
University of Arkansas
- 2026–2035
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Site PI · Recruiting · Phase 1, Phase 2
Milton S. Hershey Medical Center
- 2023–2033
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Site PI · Recruiting · Phase 1, Phase 2
Tanja Andrea Gruber
- 2023–2027
Site PI · Recruiting · Phase 1
Norman J. Lacayo